Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFIRFI Meaning: What Is an RFI?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Pharmaceutical Products for CDER Research Studies - IDIQ

U.S. Department Of Health And Human Services·Maryland

Pharmaceutical Products for CDER Research Studies - IDIQ

Closes 3/18/2026$10k – $4MRequest for Information
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Drug Evaluation and Research (CDER) requirement for Pharmaceutical Manufacturer/Supplier to provide brand name and/or generic pharmaceuticals. The FDA is seeking small business sources to determine the availability and capability of small businesses capable of providing the required supplies. The contractor will fulfill orders from the FDA on an as-need basis for drug products listed in the schedule of items. The FDA may request both brand name and any available generic products. Some key points about this opportunity include: • The NAICS code for this opportunity is 325412, Pharmaceutical Preparation Manufacturing. • The contract period of performance shall consist of five one-year ordering periods. • The contract guaranteed minimum will be $10,000, and the contract maximum of all orders issued over five years is estimated not to exceed $4,000,000. • The contractor must be able to supply a comprehensive list of pharmaceutical products to the FDA. • The contractor shall maintain a log of all pharmaceutical products purchased under this contract and shall supply a copy to the FDA upon request.

Attached files

Contact

Nick Sartain(Primary Contact)

[email protected]

(301) 796-1988

Key dates

Opened
3/5/2026
Closes
3/18/2026
Duration
5 years

Last updated

Details

Type
Request for Information
Industry
Healthcare and Medical Services
NAICS
325412
Solicitation №
CDER-2026-132721

Budget estimate

$10,000 – $4,000,000

The estimated budget for this opportunity is between $10,000 and $4,000,000 over five years. The actual budget will depend on the number and type of pharmaceutical products ordered by the FDA. Factors that may influence the likely payment range include the frequency and quantity of orders, the type of pharmaceutical products ordered, and the pricing of those products.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Transportation·United States of America

Top match · 72%

Advanced Safety Research Multiple Award Indefinite Delivery, Indefinite Quantity (IDIQ)

Closes 12/30/2026Opened 10/15/2026

U.S. Department Of Health And Human Services·Maryland

71% match

Reagents and consumables for Roche immunostainers

Closes 11/16/2026Opened 10/30/2026

U.S. Department Of Health And Human Services·South Dakota

71% match

Firm Fixed-Price Commercial Item, Area Wide IDIQ Contract for Clinical Laboratory Coagulation Equipment/Supply on a Cost-Per-Reportable-Results for the Great Plains Area OHP Department located in Aberdeen SD.

Closes 11/9/2026Opened 10/8/2026

U.S. Department Of Defense·United States of America

70% match

Solicitation for IDIQ Contract for Biology Testing of DM

Closes 12/1/2026Opened 10/29/2026

U.S. Department Of Health And Human Services·United States of America

70% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. Food and Drug Administration·United States of America

69% match

Center for Research on Complex Generics (U18) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. Department Of Transportation·United States of America

69% match

Experimental and Mathematical Biomechanics Injury Research IDIQ

Closes 11/30/2026Opened 10/15/2026

U.S. Department Of Veterans Affairs·United States of America

69% match

RFP-797-FSS-03-0001-R1: 66III Cost-Per-Test, Clinical Laboratory Analyzer

Closes 12/29/2026Opened 6/30/2026

U.S. National Institutes of Health·United States of America

68% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. Department Of Veterans Affairs·Washington

68% match

6550--Cepheid GeneXpert Testing Supplies

Closes 11/16/2026Opened 9/22/2026

U.S. National Institutes of Health·United States of America

67% match

Clinical Data, Safety and Statistical Centers (CDSSC)

Closes 5/31/2027Opened 6/24/2026

U.S. Department Of Veterans Affairs·Maryland

67% match

6550--Cepheid GeneXpert Testing Supplies

Closes 11/16/2026Opened 9/22/2026

U.S. National Institutes of Health·United States of America

67% match

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Closes 9/25/2028Opened 5/28/2025

U.S. Department Of Defense·District of Columbia

67% match

Research, Development, Test & Evaluation (RDT&E) Support for the Center for Corrosion Science and Engineering (CCSE)

Closes 11/6/2026Opened 9/25/2026

U.S. Department Of Defense·Maryland

67% match

Data & AI Mission Expert Services (DAMES) IDIQ

Closes 11/2/2026Opened 10/22/2026

U.S. Food and Drug Administration·United States of America

67% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Health And Human Services·Maryland

67% match

Access to Web of Science, EndNote and Incites

Closes 11/6/2026Opened 10/23/2026

U.S. Department Of Health And Human Services·Georgia

67% match

CDC Technical Assistance for Program Implementation, Messaging, Evaluation, and Translation Services in Support of Nutrition, Physical Activity, and Obesity Prevention

Closes 11/10/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

67% match

Single Source: Institutional Development Award (IDeA) Clinical Research Resource Center (I-CRRC)

Closes 9/27/2027Opened 5/27/2026

U.S. National Institutes of Health·United States of America

67% match

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

66% match

Diabetes Research Centers (P30 Clinical Trial Optional)

Closes 1/27/2027Opened 5/27/2025

U.S. National Institutes of Health·United States of America

66% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. National Institutes of Health·United States of America

66% match

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/4/2024

U.S. National Institutes of Health·United States of America

66% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

66% match

HIV/AIDS Clinical Trials Network Laboratory Centers

Closes 1/21/2027Opened 4/8/2026